Is This Once-Popular Growth Stock Finally Worth a Second Look in 2026?

Chewy reported fiscal Q3 revenue of $3.1 billion, up 8.3% year-over-year, and has recently swung from losses into sustained profitability with bottom-line improvement outpacing revenue growth. Subscription recurring revenue now represents 83.9% of Q3 sales (up from 80% a year earlier), driven by several million customers who spend roughly $600 annually, which lowers marginal retention costs and supports margin expansion. The stock remains depressed—trading over 80% below its COVID-era peak and about 60% below analysts' $46.19 12-month target—leaving a forward P/E near 22, suggesting potential upside if investors re-rate growth and profitability continuation.

Analysis

Market structure: Chewy (CHWY) benefits directly from rising subscription penetration (Q3 subscription revenue 83.9%) which converts fixed-costs to scalable margin; pet food manufacturers and logistics partners also win from predictable demand, while brick-and-mortar rivals (e.g., WOOF/Petco) face share pressure. Pricing power improves as LTV/CAC increases — every 100 bps rise in subscription mix likely lifts operating leverage by several hundred basis points given fixed SG&A. Cross-asset: improving profitability should compress CHWY credit spreads, lift small-cap consumer equity flows, raise call option demand (elevated IV around recent lows), and create modest pass-through pressure to corn/soy markets via pet food input demand.

Risk assessment: Tail risks include a regulatory hit to online pet pharmacy or a commodity shock (corn/soy spike >+30%) that compresses gross margin, and competitive repricing from Amazon. Time horizons differ: immediate (days) watch for earnings/guidance; short-term (1–6 months) track subscription %, churn and gross margin; long-term (1–3 years) depends on sustained ARPU ~$600/yr and churn <10%. Hidden dependencies: supplier concentration, shipping cost elasticity, and backend pharmacy regulation that could materially change margins. Key catalysts: 1) two consecutive quarters of subscription share >84% and EBITDA margin >5% would likely re-rate stock; 2) any guidance downgrade or churn uptick >100bps could trigger another leg down.

Trade implications: Direct: build a staged 2–3% portfolio long in CHWY below $20 (current implied price ~ $18–19) with a 12–18 month horizon and target exit near analyst consensus $46 (implies ~2.5x). Options: buy 3–6 month CHWY 20/30 call spreads sized to risk 0.5% portfolio to play earnings upside; alternatively buy Jan 2027 LEAP 25C if longer-term upside desired. Pair: long CHWY vs short WOOF (Petco) 1:1 for 6–12 months to capture online share shift; size net exposure to 1–2% portfolio. Rotate 1–2% from high-PE discretionary into resilient consumer staples/pet names if macro consumption softens.

Contrarian angles: Consensus underweights the sustainability of subscription economics — a durable 80%+ recurring revenue base is often underpriced at sub-$20 valuations; downside is asymmetric if Amazon or private-label accelerates lower-priced fulfillment. The market may be over-penalizing valuation reflexively (stock -80% from peak) while underestimating operating leverage; watch for repeatable margin expansion rather than one-off cost cuts. Historical parallel: companies that converted to subscription models (e.g., Netflix) saw re-ratings after consistent margin proof-points, but Chewy faces unique commodity and pharmacy regulatory risks that could blunt that path. An unintended consequence: aggressive marketing to sustain growth could mask churn deterioration — trigger sell if net retention rate falls by >200bps quarter-over-quarter.

Key Decisions for Investors

• Initiate a staged long position in CHWY totaling 2–3% of portfolio if price trades below $20; add second tranche only if next quarter shows subscription revenue ≥84% and adjusted EBITDA margin >3%; set a profit target near $46 or within 12–18 months and a hard stop-loss at 25% below entry or if subscription share drops <75%.
• Deploy options: buy a 3–6 month CHWY 20/30 call spread sized to risk 0.5% of portfolio to capture an earnings/ guidance re-rating; if bullish long-term, buy Jan 2027 CHWY 25 calls (LEAP) sized to 0.5–1% risk budget.
• Execute a 6–12 month pair trade: long CHWY vs short WOOF (Petco) 1:1, net exposure 1–2% of portfolio to exploit online subscription secular gains; unwind if CHWY churn rises >100bps or WOOF demonstrates store-led margin recovery.
• Reduce 1–2% exposure to high-PE consumer discretionary names and reallocate to consumer staples/pet retail exposure if macro consumer indicators (CPI services, consumer discretionary spending) weaken over next 3 months; monitor corn/soy futures — if price rises >30% from current levels, trim CHWY position by 50%.